India continues rise as a global drug power

Once notorious for cheap knockoffs, India is assuming a mainstream role in the global drug industry thanks to stronger patent protections and cost pressures on name-brand drug makers in the West.  "Manufacturing, packaging and formulation are moving to India," says an industry consultant, who arranges tours of Indian factories for Western pharma execs thinking of outsourcing. Article

 

Suggested Articles

The FDA is bracing for drug and medical supply shortages in the U.S. as the COVID-19 outbreak from China continues to spread globally.

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.